C3 Med Tech

Yash Nagarsheth (Co-founder & Director) is the product inventor and technical lead — the University of Michigan engineer whose ophthalmic industry experience identified the gap between expensive hospital-grade slit lamps and fundus cameras (which require trained specialists and cost lakhs) and the emerging possibility of smartphone-based optical systems that could perform equivalent diagnostic imaging at a fraction of the cost. His five years working specifically in the ophthalmic device industry gave him the precise domain knowledge needed to design medically valid, clinically accurate, diagnostically reliable devices. Alisha Nagarsheth (Co-founder) handles marketing and business development — connecting the technically complex device to the health system buyers (hospitals, eye camps, government health programmes, telemedicine platforms) who represent C3 Med-Tech's distribution channels.

C3 Med Tech manufactures two FDA-approved, smartphone-based portable ophthalmic screening devices — the C3 Vision (a portable slit lamp that attaches to any smartphone and images the anterior segment of the eye: cornea, lens, iris, and anterior chamber, enabling diagnosis of cataracts and other anterior eye diseases) and the C3 Fundus (a portable retinal imaging device that attaches to any smartphone and images the posterior segment of the eye: retina, optic nerve, macula, enabling diagnosis of diabetic retinopathy, glaucoma, macular degeneration, and retinopathy of prematurity) — allowing non-specialists and community health workers to conduct hospital-quality eye screenings in remote, rural, and resource-limited settings using devices they already own (smartphones).

Amount Asked: ₹35 lakhs Equity Offered: 6% Implied Pre-Money Valuation: ₹5.83 crore

C3 Med-Tech's pitch was the fourth and final of Episode 32 (Finale Week Day 2) — closing the episode after Thea and Sid's proposal ring no-deal, Experiential Etc's holographic agency no-deal, and Grow Fitter's fitness rewards Aman deal with Season 1's most medically mission-critical product: a smartphone-based portable eye screening device that could prevent avoidable blindness in India's most underserved communities. They have a very nice vision of saving people's vision with timely diagnosis of the eye. The machines available in hospitals can diagnose it but it requires highly skilled technicians and doctors (optometrists). Due to this difficulty, eye check-up camps cannot do it due to resource constraints. They have products like C3 Vision and C3 Fundus Cam. Shark Peyush offered to volunteer for a demo of the said products.

Namita Thapar — whose Emcure Pharmaceuticals background gave her the deepest institutional healthcare market knowledge — had the most informed concern: the device's current pricing made it inaccessible to the grassroots health workers who were the ideal users. Peyush Bansal was the most constructively engaged Shark: Shark Peyush Bansal suggested making a device at an affordable price will be a great thing as there is a huge market for this device.

All 4 sharks except Peyush did not like the idea and backed out without offering any deal.

no final deal